In Germany, a few Muslim refugees convert to Christianity

December 10, 2016

Berlin, Dec 10: Clad in white at a Berlin church, asylum seekers Saeed, Veronica, Farida and Matin were just about to become Christians on a recent Sunday.chrs

"Do you believe from the bottom of your heart that Jesus Christ is your Lord and saviour, and will you follow him every day of your life?" Pastor Matthias Linke asked them. "If so, say yes."

All four replied with a frank "Ja", to the enthusiastic applause of the faithful at the Free Evangelical Church, and were plunged head-to-toe into a baptism basin.

"I am very, very happy, I feel... how to say?", said 20-year-old Iran native Matin right after his baptism, placing his hand on his chest.

Muslim refugees have recently been taking the same step throughout Germany, where nearly 900,000 asylum seekers arrived in 2015.

Church leaders have confirmed a notable, though not huge, trend upward, but have not provided statistics.

"In our diocese, there are several groups of refugees who are preparing for baptism, and there are more and more requests," said Felix Goldinger, a Catholic priest in Speyer, southwestern Germany.

Many come from Iran and Afghanistan, some from Syria or Eritrea, he said.

"I am currently handling a group of 20 people but I do not know how many will go through until baptism," he said.

Over the course of their preparations, which last nearly a year in Goldinger's diocese, potential converts are encouraged to weigh their own motivations.

"During this period, it is important that they examine their original religion, Islam, and the reasons why they want to change it," he said.
"We are obviously pleased that people want to be baptised, but it is very important for us that they are sure of their decision."

Goldinger said that "many people recall what they have experienced in their country", including "terrorist acts committed in the name of religion. They see Christianity as a religion of love and respect for life."

In Iran, said Linke, many had been in contact with unrecognised churches in the Islamic republic, where conversion is prohibited, and then had to flee.

Other refugees met Christians on their journey to Europe.

This was the case for Saeed, a 31-year-old aeronautical engineer who spent four months in Turkey with a Christian and then became interested in his religion. Like fellow new convert Veronica, Saeed is from Afghanistan.

Reading the Bible "helped in times of trouble," he says.

It was in Greece, recalled Matin, that he first came in touch with the Christian faith. After he arrived in Germany, he approached the Free Evangelical Church through his German friends.

His sister Farida followed him and they began preparations -- in German and Farsi -- for baptism.

Farida said she "was looking for a church" and wanted to choose her religion "in complete freedom".

"This is a very important reason to become a Christian," said Linke.

Among refugees who adopt Germany's dominant religion, he said, "there is a strong desire to decide for themselves, in a free and personal way, the direction of their lives".

Churches concede that some conversions are motivated by a desire to integrate into German society, or even by the belief that they will increase their chances of gaining political asylum.

Countries that send Muslim converts to Christianity back to their homelands put them potentially at great risk.

Apostasy or blasphemy can be punished with jail or death sentences in some Muslim countries, among them Iran, Mauritania, Saudi Arabia and Afghanistan.

For jihadist groups such as the Islamic State, conversion is also a punishable sin.

"There are refugees who think that if they convert, it will be easier for them to stay here, but it is not systematic," Goldinger said.

"Do they change religion in order to be able to stay in Germany? This is an important issue for the authorities," said Linke, who is often consulted by the state Office for Migration and Refugees.

"I have no guarantees, I can only ask them: 'do you really believe with all your heart?' After their baptism, most of them live as Christians and come to church," he added.

Outside their new community, the converts nonetheless usually try to remain discreet.

"They may face difficult situations in refugee homes, where the majority are Muslims," said Thomas Klammt, in charge of migration issues at the Union of Free German Evangelical Churches.

"They may also be afraid for their families left behind in their country of origin."

Matin said he stays in contact with relatives back home -- especially his mother, who had "accepted" his willingness to convert.

"She calls me every Sunday to ask if I have been to mass," he said, laughing.

Comments

shaji
 - 
Sunday, 11 Dec 2016

Christian missionaries are luring these deserted people to change their religion. This is their tactics being practiced in many poor countries.

Rashid
 - 
Sunday, 11 Dec 2016

One , who really applied muslim or community connected muslim , never select other religion... Allah considers eligible to 'jannah' , whether he dies as 'muslim' ... that is why muslim always prays to die as muslims...

Mohammad.n
 - 
Saturday, 10 Dec 2016

Failed in Allah's test

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Moscow, Aug 7: Russia will register its first vaccine against the coronavirus on August 12, Deputy Health Minister Oleg Gridnev said on Friday.

The vaccine has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry.

"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa.

According to the minister, the effectiveness of the vaccine will be judged when the population immunity has formed.

Clinical trials of the vaccine began on June 18 and included 38 volunteers. All of the participants developed immunity. 

The first group was discharged on July 15 and the second group on July 20.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 22,2020

Houston, Jul 22: China said on Wednesday that the US has ordered it to close its consulate in Houston in what an official called an outrageous and unjustified move that will sabotage China-US relations.

Foreign ministry spokesperson Wang Wenbin condemned the action, which comes as tensions rise between the world's two largest economies. He warned of firm countermeasures if the US does not reverse its decision.

The unilateral closure of China's consulate general in Houston within a short period of time is an unprecedented escalation of its recent actions against China, Wang said at a daily news briefing.

There was no immediate confirmation or explanation from the U.S. side.

Media reports in Houston said that authorities had responded to reports of a fire at the consulate. Witnesses said that people were burning paper in what appeared to be trash cans, the Houston Chronicle reported, citing police.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.